Your browser doesn't support javascript.
loading
MCL1 Is Required for Maintenance of Intestinal Homeostasis and Prevention of Carcinogenesis in Mice.
Healy, Marc E; Boege, Yannick; Hodder, Michael C; Böhm, Friederike; Malehmir, Mohsen; Scherr, Anna-Lena; Jetzer, Jasna; Chan, Lap Kwan; Parrotta, Rossella; Jacobs, Kurt; Clerbaux, Laure-Alix; Kreutzer, Susanne; Campbell, Andrew; Gilchrist, Ella; Gilroy, Kathryn; Rodewald, Ann-Katrin; Honcharova-Biletska, Hanna; Schimmer, Roman; Vélez, Karelia; Büeler, Simone; Cammareri, Patrizia; Kalna, Gabriela; Wenning, Anna S; McCoy, Kathy D; Gomez de Agüero, Mercedes; Schulze-Bergkamen, Henning; Klose, Christoph S N; Unger, Kristian; Macpherson, Andrew J; Moor, Andreas E; Köhler, Bruno; Sansom, Owen J; Heikenwälder, Mathias; Weber, Achim.
Afiliación
  • Healy ME; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland; Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
  • Boege Y; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Hodder MC; Cancer Research UK Beatson Institute, Garscube Estate, Bearsden, Glasgow, UK; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, UK. Electronic address: achim.weber@usz.ch.
  • Böhm F; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Malehmir M; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Scherr AL; National Center for Tumor Diseases, Department of Medical Oncology and Heidelberg University Hospital, Internal Medicine VI, Heidelberg, Germany.
  • Jetzer J; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Chan LK; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Parrotta R; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Jacobs K; Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
  • Clerbaux LA; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland; Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
  • Kreutzer S; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Campbell A; Cancer Research UK Beatson Institute, Garscube Estate, Bearsden, Glasgow, UK.
  • Gilchrist E; Cancer Research UK Beatson Institute, Garscube Estate, Bearsden, Glasgow, UK.
  • Gilroy K; Cancer Research UK Beatson Institute, Garscube Estate, Bearsden, Glasgow, UK.
  • Rodewald AK; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Honcharova-Biletska H; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Schimmer R; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Vélez K; Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
  • Büeler S; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Cammareri P; Cancer Research UK Beatson Institute, Garscube Estate, Bearsden, Glasgow, UK.
  • Kalna G; Cancer Research UK Beatson Institute, Garscube Estate, Bearsden, Glasgow, UK.
  • Wenning AS; Maurice Müller Laboratories (DKF), Universitätsklinik für Viszerale Chirurgie und Medizin Inselspital, University of Bern, Bern, Switzerland.
  • McCoy KD; Maurice Müller Laboratories (DKF), Universitätsklinik für Viszerale Chirurgie und Medizin Inselspital, University of Bern, Bern, Switzerland; Department of Physiology and Pharmacology and Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary
  • Gomez de Agüero M; Maurice Müller Laboratories (DKF), Universitätsklinik für Viszerale Chirurgie und Medizin Inselspital, University of Bern, Bern, Switzerland.
  • Schulze-Bergkamen H; National Center for Tumor Diseases, Department of Medical Oncology and Heidelberg University Hospital, Internal Medicine VI, Heidelberg, Germany.
  • Klose CSN; Institute of Microbiology, Infectious Diseases and Immunology, Charité - Universitätsmedizin Berlin, Germany.
  • Unger K; Research Unit of Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg Germany.
  • Macpherson AJ; Maurice Müller Laboratories (DKF), Universitätsklinik für Viszerale Chirurgie und Medizin Inselspital, University of Bern, Bern, Switzerland.
  • Moor AE; Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
  • Köhler B; National Center for Tumor Diseases, Department of Medical Oncology and Heidelberg University Hospital, Internal Medicine VI, Heidelberg, Germany.
  • Sansom OJ; Cancer Research UK Beatson Institute, Garscube Estate, Bearsden, Glasgow, UK; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, UK. Electronic address: o.sansom@beatson.gla.ac.uk.
  • Heikenwälder M; Division of Chronic Inflammation and Cancer, Deutsches Krebs-Forschungszentrum (DKFZ), Heidelberg, Germany. Electronic address: m.heikenwaelder@dkfz.de.
  • Weber A; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland; Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland. Electronic address: achim.weber@usz.ch.
Gastroenterology ; 159(1): 183-199, 2020 07.
Article en En | MEDLINE | ID: mdl-32179094
BACKGROUND & AIMS: Intestinal epithelial homeostasis depends on a tightly regulated balance between intestinal epithelial cell (IEC) death and proliferation. While the disruption of several IEC death regulating factors result in intestinal inflammation, the loss of the anti-apoptotic BCL2 family members BCL2 and BCL2L1 has no effect on intestinal homeostasis in mice. We investigated the functions of the antiapoptotic protein MCL1, another member of the BCL2 family, in intestinal homeostasis in mice. METHODS: We generated mice with IEC-specific disruption of Mcl1 (Mcl1ΔIEC mice) or tamoxifen-inducible IEC-specific disruption of Mcl1 (i-Mcl1ΔIEC mice); these mice and mice with full-length Mcl1 (controls) were raised under normal or germ-free conditions. Mice were analyzed by endoscopy and for intestinal epithelial barrier permeability. Intestinal tissues were analyzed by histology, in situ hybridization, proliferation assays, and immunoblots. Levels of calprotectin, a marker of intestinal inflammation, were measured in intestinal tissues and feces. RESULTS: Mcl1ΔIEC mice spontaneously developed apoptotic enterocolopathy, characterized by increased IEC apoptosis, hyperproliferative crypts, epithelial barrier dysfunction, and chronic inflammation. Loss of MCL1 retained intestinal crypts in a hyperproliferated state and prevented the differentiation of intestinal stem cells. Proliferation of intestinal stem cells in MCL1-deficient mice required WNT signaling and was associated with DNA damage accumulation. By 1 year of age, Mcl1ΔIEC mice developed intestinal tumors with morphologic and genetic features of human adenomas and carcinomas. Germ-free housing of Mcl1ΔIEC mice reduced markers of microbiota-induced intestinal inflammation but not tumor development. CONCLUSION: The antiapoptotic protein MCL1, a member of the BCL2 family, is required for maintenance of intestinal homeostasis and prevention of carcinogenesis in mice. Loss of MCL1 results in development of intestinal carcinomas, even under germ-free conditions, and therefore does not involve microbe-induced chronic inflammation. Mcl1ΔIEC mice might be used to study apoptotic enterocolopathy and inflammatory bowel diseases.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Proteína 1 de la Secuencia de Leucemia de Células Mieloides / Mucosa Intestinal / Neoplasias Intestinales Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Gastroenterology Año: 2020 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Proteína 1 de la Secuencia de Leucemia de Células Mieloides / Mucosa Intestinal / Neoplasias Intestinales Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Gastroenterology Año: 2020 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos